Brief: ViroGates Announces CE-IVD Approval For Suparnostic Turbilatex

ViroGates A/S

15/03/2021 14:01

March 15 (Reuters) - ViroGates A/S  VIROG.CO :
    * VIROGATES ANNOUNCES CE-IVD APPROVAL FOR SUPARNOSTIC®
TURBILATEX
ON THE ABBOTT ALINITY PLATFORM
    * TODAY'S ANNOUNCEMENT MEANS HOSPITALS USING RECENT ABBOTT
ALINITY
INSTRUMENT PLATFORM CAN NOW RUN SUPARNOSTIC® TURBILATEX

Source text: https://bit.ly/2NiYATY
Further company coverage:  VIROG.CO 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 6600;))